Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation

F Felix Oluwasegun Ishabiyi H Haruna Isiyaku Umar T Tanmoy Dutta O Okoyenta Celestina Onyinye O Olusola Daniel Damola L Leyla Budagova D Denekew Temesgen M Mohammed Bourhia R Ridwan Opeyemi Bello E Esmael M. Alyami M Mona Alsolami O Omar A. Almohammed

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 02, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (12)

F

Felix Oluwasegun Ishabiyi

H

Haruna Isiyaku Umar

T

Tanmoy Dutta

O

Okoyenta Celestina Onyinye

O

Olusola Daniel Damola

L

Leyla Budagova

D

Denekew Temesgen

M

Mohammed Bourhia

R

Ridwan Opeyemi Bello

E

Esmael M. Alyami

M

Mona Alsolami

O

Omar A. Almohammed